by
Gus Iversen, Editor in Chief | December 13, 2017
HCB News: This year AI is the soup of the day at RSNA. Everyone is talking about it - but when you look ahead and at what you're working on - what will we be talking about next year?
DP: AI probably has a couple years left (laughs). As an industry, I think we're really in the early stages of talking about this. We actually did a symposium at TCT, a heart coronary trade show in Denver, this year on AI and that community is very excited about it - so it’s starting to hit all the different -ologies and departments and different applications in neuro and oncology. I think it will be around for a while, and that’s really exciting.
I think next year we will be hearing more about outcomes and value.That conversation died down a little bit this year, but I think once things settle down on where the health system is going, there will be a rejuvenated and renewed buzz about focusing on outcomes and value-based care. Innovation is important, but like we talked about earlier, it's not just technology; it's business model innovation that's going to be a continuing focus as well.
Back to HCB News
